IMAX IMAX CORP
Photographic Equipment & Supplies · NYSE · SEC CIK 921582 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY28.1%
TTM net income YoY239.0%
TTM EPS YoY232.4%
Revenue 3-yr CAGR7.8%
Net income 3-yr CAGR74.1%
Margins
Gross margin63.5%
Operating margin26.8%
Net margin27.7%
FCF margin30.2%
EBITDA margin42.0%
Returns
ROE31.9%
ROA14.0%
ROIC (approx.)52.9%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets42.7%
Debt / equity0.00x
Current ratio—
Interest coverage17.45x
Cash quality & payout
Operating cash flow / net income1.13x
Accruals ratio-1.8%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $410.21M | $352.21M | $374.84M | $300.81M | $254.88M |
| Cost of revenue | $164.02M | $162.01M | $160.50M | $144.45M | $120.48M |
| Gross profit | $246.19M | $190.20M | $214.34M | $156.35M | $134.41M |
| R&D expense | $5.82M | $5.10M | $10.11M | $5.30M | $6.94M |
| SG&A expense | $138.46M | $132.70M | $144.41M | $138.04M | $117.32M |
| Operating income | $84.23M | $43.86M | $50.40M | -$4.83M | $10.98M |
| Interest expense | $7.36M | $8.08M | $6.82M | $5.88M | $7.09M |
| Pretax income | $63.29M | $37.70M | $46.12M | -$9.77M | $10.99M |
| Income tax | $17.77M | $5.00M | $13.05M | $10.11M | $20.56M |
| Net income | $34.88M | $26.06M | $25.34M | -$22.80M | -$22.33M |
| EBITDA | $146.68M | $109.36M | $110.42M | $51.83M | $67.07M |
| EPS (basic) | 0.65 | 0.49 | 0.47 | -0.40 | -0.38 |
| EPS (diluted) | 0.63 | 0.48 | 0.46 | -0.40 | -0.38 |
| Weighted avg. shares (diluted) | 55.54M | 53.86M | 55.15M | 56.67M | 59.13M |
| Balance sheet | |||||
| Cash & equivalents | $151.17M | $100.59M | $76.20M | $97.40M | $189.71M |
| Receivables | $108.08M | $107.67M | $136.26M | $136.14M | $110.05M |
| Inventory | $32.51M | $32.84M | $31.58M | $31.53M | $26.92M |
| PP&E, net | $242.91M | $240.13M | $243.30M | $252.90M | $260.35M |
| Goodwill | $45.81M | $52.81M | $52.81M | $52.81M | $39.03M |
| Intangibles | $32.39M | $35.12M | $35.02M | $32.74M | $23.08M |
| Total assets | $894.03M | $830.40M | $814.67M | $821.15M | $883.25M |
| Long-term debt | — | — | — | — | $2.47M |
| Total debt | — | — | — | — | $2.47M |
| Total liabilities | $466.30M | $452.18M | $469.08M | $491.39M | $452.88M |
| Shareholders' equity | $337.89M | $299.47M | $273.14M | $263.36M | $356.08M |
| Net debt | — | — | — | — | -$187.24M |
| Shares outstanding | 53.92M | 52.95M | 53.26M | 54.15M | 58.65M |
| Cash flow statement | |||||
| Operating cash flow | $127.07M | $70.84M | $58.62M | $17.32M | $6.07M |
| Capital expenditure | $8.17M | $8.43M | $6.49M | $8.42M | $3.59M |
| Free cash flow | $118.90M | $62.41M | $52.12M | $8.90M | $2.48M |
| Investing cash flow | -$41.92M | -$41.22M | -$31.79M | -$53.29M | -$7,000 |
| Financing cash flow | -$34.08M | -$6.04M | -$48.53M | -$58.51M | -$132.72M |
| Depreciation & amortization | $62.45M | $65.50M | $60.02M | $56.66M | $56.08M |
| Stock-based compensation | $26.60M | $22.80M | $23.60M | $27.00M | $25.60M |
| Share buybacks | — | — | — | — | $13.90M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.